CYTOKINETICS INC — Director's Dealing 2021

Apr 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-04-15

Reporting Person: SMITH SANDFORD D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-15	Common Stock	M	5000	$9.45	Acquired	5920	Direct
2021-04-15	Common Stock	S	5000	$25.5	Disposed	920	Direct
2021-04-15	Common Stock	M	5714	$8.75	Acquired	6634	Direct
2021-04-15	Common Stock	S	5714	$25.0	Disposed	920	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-15	Non-Qualified Stock Option (right to buy)	$8.75	M	5714	Disposed	2028-01-02	Common Stock (5714)	Direct
2021-04-15	Non-Qualified Stock Option (right to buy)	$9.45	M	5000	Disposed	2028-05-16	Common Stock (5000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021.

F2: Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.